A T Natarajan Selected Research

Chromosome Aberrations (Chromosome Abnormalities)

8/2013	From DNA damage to chromosome aberrations: joining the break.
1/2010	Relationship between DNA repair and formation of sister chromatid exchanges and chromatid aberrations under the influence of poly(ADP-ribose) polymerase inhibition by 3-aminobenzamide.
1/2004	Chromosomal aberrations in arsenic-exposed human populations: a review with special reference to a comprehensive study in West Bengal, India.
1/2003	Chromosomal aberrations and sister chromatid exchanges in individuals exposed to arsenic through drinking water in West Bengal, India.
7/2002	Chromosomal aberrations: formation, identification and distribution.
12/2001	Accurate detection of true incomplete exchanges in human lymphocytes exposed to neutron radiation using chromosome painting in combination with a telomeric PNA probe.
10/2001	Association between genetic polymorphisms and biomarkers in styrene-exposed workers.
5/2001	Induction and persistence of micronuclei, sister-chromatid exchanges and chromosomal aberrations in splenocytes and bone-marrow cells of rats exposed to ethylene oxide.
4/2001	Complementation of chromosomal aberrations in AT/NBS hybrids: inadequacy of RDS as an endpoint in complementation studies with immortal NBS cells.
1/2001	Fluorescence in situ hybridization (FISH) in genetic toxicology.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A T Natarajan Research Topics

Disease

17	Chromosome Aberrations (Chromosome Abnormalities) 08/2013 - 02/2000
5	Neoplasms (Cancer) 04/2007 - 01/2000
3	Chromosome Breakage 03/2007 - 11/2000
2	Cockayne Syndrome (Syndrome, Cockayne) 05/2001 - 03/2000
1	Chromosomal Instability (Chromosome Stability) 01/2011
1	Aneuploidy (Aneuploid) 01/2011
1	Arsenic Poisoning 04/2002
1	Xeroderma Pigmentosum (Kaposi's Disease) 05/2001

Drug/Important Bio-Agent (IBA)

11	DNA (Deoxyribonucleic Acid)IBA 08/2013 - 01/2000
3	ArsenicIBA 04/2007 - 01/2003
3	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 07/2002 - 10/2000
2	Biomarkers (Surrogate Marker)IBA 01/2011 - 01/2004
2	CarcinogensIBA 01/2004 - 01/2000
2	Drinking WaterIBA 01/2003 - 04/2002
2	DNA ProbesIBA 12/2001 - 06/2000
2	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 10/2001 - 08/2000
2	Ethylene Oxide (Oxirane)IBA 05/2001 - 01/2000
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2010
1	3-aminobenzamideIBA 01/2010
1	CopperIBA 04/2007
1	Alkylating AgentsIBA 03/2002
1	propylene oxideIBA 03/2002
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 10/2001
1	EnzymesIBA 10/2001
1	Epoxide HydrolasesIBA 10/2001
1	XenobioticsIBA 10/2001
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 10/2001
1	MitogensIBA 05/2001
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 05/2001
1	Biological ProductsIBA 01/2001
1	Butyric Acid (Butanoic Acid)IBA 11/2000
1	EuchromatinIBA 09/2000
1	HeterochromatinIBA 09/2000
1	AlkaliesIBA 08/2000
1	Proteins (Proteins, Gene)FDA Link 08/2000
1	Radon-222IBA 04/2000
1	Deoxyribonuclease I (Nickase)IBA 03/2000
1	Ammonium CompoundsIBA 03/2000
1	Peptide Nucleic AcidsIBA 02/2000
1	B-Form DNA (B-DNA)IBA 01/2000
1	DNA AdductsIBA 01/2000

Therapy/Procedure

1	Radiotherapy 11/2001
1	Intraperitoneal Injections 05/2001